Point-of-care diagnostics
5 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- EDEN TECH
French microfluidics SME developing miniaturized devices for point-of-care diagnostics, water remediation, and organ-on-chip drug testing.
“FIT-SEP targets sepsis diagnosis via integrated microfluidics, IPANEMA develops paper-based nucleic acid testing, and SMD-SPH builds drug-testing platforms using spheroid models.”
PrimarySMEFR10 projects - CARL ZEISS AG
Global optics leader contributing optical coherence tomography, bio-photonic imaging, and miniaturized diagnostic device expertise to EU research consortia.
“HandheldOCT (their largest-funded project at EUR 995,060) targets handheld diagnostic devices with point-of-care and diagnostic-driven therapy keywords.”
DE6 projects - CNM TECHNOLOGIES GMBH
German SME manufacturing carbon nanomembranes for water purification, filtration, and separation applications.
“PoC-ID project (EUR 398K) developed a platform for ultra-sensitive diagnostics for infectious diseases.”
SMEDE5 projects - VALOTEC
French SME specializing in miniaturized electronics, wireless in-body communication, and energy harvesting for medical devices and implantables.
“KardiaTool developed an integrated POC solution for non-invasive heart failure diagnosis and therapy monitoring.”
SMEFR4 projects - BIONOS BIOTECH SL
Spanish biotech SME specializing in microalgae-derived cosmeceuticals, nutraceuticals, and multi-omics biological research for health applications.
“PHOCNOSIS developed advanced nanophotonic devices for fast cardiovascular disease diagnosis.”
SMEES3 projects